fda glp-1 compounding crackdown news october 2025 FDA Crackdown Puts Pressure on

Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown potent metabolic benefits in type 2 diabetes (T2D) and obesity, but their efficacy and safety in CS remain unexplored

Initially designed for managing type 2 diabetes, these GLP-1 receptor agonists have proven so effective at curbing appetite that theyre now being prescribed off-label for weight loss

Heres what the term really means, what the science says about low-dose GLP-1 use, and why the distinction matters, especially for women in midlife.

After screening, curcumin, syringic acid, and resveratrol were found in high affinity with DPP IV enzymes

Do not exceed 4 fiber supplement gummies per day or daily

For many women, metabolic health changes with age